Handelsbanken Fonder’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$252M Buy
1,959,794
+95,489
+5% +$11.2M 0.72% 24
2026
Q1
$224M Buy
1,864,305
+21,263
+1% +$2.45M 0.75% 18
2025
Q4
$194M Buy
1,843,042
+224,752
+14% +$21.1M 0.59% 24
2025
Q3
$136M Sell
1,618,290
-26,136
-2% -$2.15M 0.43% 37
2025
Q2
$130M Sell
1,644,426
-120,748
-7% -$9.6M 0.46% 39
2025
Q1
$158M Sell
1,765,174
-1,332,476
-43% -$124M 0.65% 24
2024
Q4
$308M Sell
3,097,650
-32,392
-1% -$3.34M 1.18% 12
2024
Q3
$355M Buy
3,130,042
+967,462
+45% +$115M 1.41% 10
2024
Q2
$268M Buy
2,162,580
+269,554
+14% +$34.7M 1.16% 10
2024
Q1
$250M Buy
1,893,026
+186,134
+11% +$22.9M 1.08% 11
2023
Q4
$186M Buy
1,706,892
+62,026
+4% +$6.44M 0.9% 18
2023
Q3
$169M Buy
1,644,866
+108,654
+7% +$11.7M 0.95% 15
2023
Q2
$177M Buy
1,536,212
+389,764
+34% +$44.3M 0.95% 15
2023
Q1
$122M Sell
1,146,448
-2,317
-0.2% -$250K 0.71% 23
2022
Q4
$127M Buy
1,148,765
+111,078
+11% +$11.4M 0.8% 20
2022
Q3
$89.4M Buy
1,037,687
+88,503
+9% +$7.9M 0.6% 27
2022
Q2
$86.5M Buy
949,184
+97,921
+12% +$8.68M 0.56% 31
2022
Q1
$69.8M Sell
851,263
-86,137
-9% -$6.79M 0.39% 51
2021
Q4
$71.8M Sell
937,400
-268,402
-22% -$21.4M 0.35% 57
2021
Q3
$90.6M Sell
1,205,802
-81,361
-6% -$6.19M 0.47% 40
2021
Q2
$100M Buy
1,287,163
+89,237
+7% +$6.64M 0.52% 34
2021
Q1
$88.1M Buy
1,197,926
+241,485
+25% +$17.8M 0.5% 38
2020
Q4
$74.7M Buy
956,441
+123,666
+15% +$9.46M 0.45% 52
2020
Q3
$65.9M Buy
832,775
+27,146
+3% +$2.13M 0.48% 45
2020
Q2
$59.4M Buy
805,629
+678,246
+532% +$51.1M 0.5% 42
2020
Q1
$9.35M Sell
127,383
-596,453
-82% -$46.9M 0.2% 121
2019
Q4
$62.8M Sell
723,836
-229,512
-24% -$18.9M 1.09% 24
2019
Q3
$76.6M Buy
953,348
+5,240
+0.6% +$420K 1.55% 18
2019
Q2
$75.9M Sell
948,108
-44,016
-4% -$3.37M 1.4% 18
2019
Q1
$78.7M Buy
992,124
+8,525
+0.9% +$638K 1.52% 17
2018
Q4
$71.7M Buy
983,599
+202,839
+26% +$14.3M 1.45% 17
2018
Q3
$52.9M Buy
780,760
+258,856
+50% +$16.5M 0.99% 31
2018
Q2
$30.2M Buy
521,904
+457,976
+716% +$25.8M 0.59% 58
2018
Q1
$3.32M Buy
63,928
+28,296
+79% +$1.53M 0.07% 162
2017
Q4
$1.91M Sell
35,632
-53,448
-60% -$2.96M 0.04% 158
2017
Q3
$5.44M Sell
89,080
-10,480
-11% -$635K 0.13% 132
2017
Q2
$6.09M Sell
99,560
-14,672
-13% -$893K 0.16% 120
2017
Q1
$6.93M Buy
114,232
+55,544
+95% +$3.37M 0.19% 99
2016
Q4
$3.3M Buy
58,688
+47,160
+409% +$2.76M 0.1% 124
2016
Q3
$687K Sell
11,528
-10,858
-49% -$635K 0.02% 153
2016
Q2
$1.23M Hold
22,386
0.05% 122
2016
Q1
$1.13M Sell
22,386
-341,111
-94% -$16.7M 0.05% 126
2015
Q4
$18.3M Buy
+363,497
New +$18.3M 0.35% 90

Other funds holding MRK

Handelsbanken Fonder's MRK Position: Q2 2026 in Review

Handelsbanken Fonder increased its Merck (MRK) stake by 5.1% in Q2 2026, buying an estimated $11.2M and bringing the position to 1,959,794 shares worth $252M. The position accounts for 0.72% of the portfolio, ranked #24.

Handelsbanken Fonder first reported a position in MRK in Q4 2015 and has held it in 43 quarters since. The position peaked at $355M in Q3 2024. 1,914 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Handelsbanken Fonder held 1,959,794 shares of Merck worth $252M as of Q2 2026.
  • Handelsbanken Fonder bought 95,489 Merck shares in Q2 2026, an estimated $11.2M.
  • Merck made up 0.72% of Handelsbanken Fonder's portfolio in Q2 2026, its #24 holding.
  • Handelsbanken Fonder first reported a position in Merck in Q4 2015 and has held it in 43 quarters since.
  • Handelsbanken Fonder's Merck position peaked at $355M in Q3 2024.
  • 1,914 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.